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Abstract
Introduction: Hypertension and obesity are common problems among diabetic
patients accelerating progression of vascular diabetic complications. 
Material and methods: A two-stage stratified random sampling design was used,
and individuals aged 15 years and over were interviewed. This cross-sectional
study evaluated lipid abnormalities of 117 obese type 2 diabetic patients 
(28 males and 89 females), and 56 hypertensive obese type 2 diabetic patients
(22 males and 34 females). Total cholesterol (TC), triglycerides (TG), low-density
lipoprotein cholesterol (LDL-C), very-low-density lipoprotein cholesterol (VLDL-C)
and high-density lipoprotein cholesterol (HDL-C) concentrations were assayed
using standard biochemical methods. 
Results: Hypertensive obese type 2 diabetic females had significantly higher
mean serum concentrations of TC (p = 0.043), TG (p = 0.046), LDL-C (p = 0.040),
TC/HDL-C ratio (p = 0.001) and LDL-C/HDL-C ratio (p = 0.003) compared with
hypertensive obese non-diabetic females. Similar results were found in
hypertensive obese type 2 diabetic males compared with hypertensive obese
non-diabetic males. Hypertensive obese type 2 diabetic females had significantly
higher serum TC, TG and TC/HDL-C ratio (p < 0.05) than hypertensive obese
type 2 diabetic males. Hypertensive obese type 2 diabetic females had
significantly higher mean serum concentrations of TG (p = 0.03) and TC 
(p = 0.01) than obese type 2 diabetic females. There was a significant association
between blood glucose and LDL-C concentrations in type 2 diabetic subjects 
(r = 0.36; p < 0.05).
Conclusion: Obese hypertensive type 2 diabetic females are exposed more
profoundly to risk factors including atherogenic dyslipidaemia compared with
males.
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Introduction
Type 2 diabetes mellitus is one of the most common chronic diseases
the world over, and the number of people with diabetes mellitus has risen
sharply in recent years [1]. The World Health Organization (WHO) estimated
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the worldwide prevalence of diabetes mellitus in
adults to be around 173 million in 2002 and
predicted that there will be at least 350 mln people
with type 2 diabetes by 2030 [2]. The largest share
of this increase will occur in developing countries,
which is expected to show the same current
pattern of concentration of cases in the 45-64-year
age group [3]. In the Americas, it is estimated that
34 mln persons have diabetes mellitus [4]. 
The prevalence of diabetes mellitus is high 
in Jamaica and the Caribbean and many patients
have poor metabolic control [5, 6]. Heart disease is
the leading cause of death in persons with
diabetes mellitus [7]. Cardiovascular disease in
diabetes mellitus is multi-factorial and risk factors
include hypertension, dyslipidaemia, insulin
resistance and central obesity [8].
Obesity can be described as an imbalance
between energy intake and expenditure such that
excess energy is stored in fat cells, which enlarge
or increase in number. Obesity is defined as a body
mass index (BMI) of > 30 kg/m2, according to WHO
criteria [9]. Obesity and overweight are significant
public health problems worldwide, affecting 
an estimated 1 billion persons and contributing 
to hypertension, type 2 diabetes mellitus,
cardiovascular disease, and death [10-12]. Its
prevalence in developed countries, such as the
United States, is as high as 26.6% in men and
32.2% in women above age 20 years [13]. 
In the United Kingdom, 12% of adult females are
obese and 24% overweight, but the rate of increase
is faster [14]. The gradient in obesity in women
(Nigeria 5%, urban Cameroon 13%, Jamaica 18%,
Barbados 30% and Chicago 36%) was found to be
closely correlated with economic development 
and with the prevalence of hypertension [15].
Ragoobirsingh et al. reported that Jamaica has
a point prevalence of obesity with truncal 36.2%
and gynoid 34.1%, in the 15 and over age group [16].
In Barbados, data show an increase in obesity
prevalence across four surveys, which were 
done in 1969, 1981, 1987, and 1992 [17]. The Wildey
population study of Barbadians aged over 40
showed prevalence in women three times that of
men, 30% vs. 10% [18].
The Caribbean has demonstrated an increasing
prevalence of type 2 diabetes mellitus associated
with obesity due to the recent transition to high
consumption of energy-dense foods and increasing
inactivity [19]. In Jamaica, the adjusted prevalence
rates (95% CI) are 9.5% (7.0-12.0) for men and
15.7% (13.2-18.3) for women in a population of over
2.6 m [20]. The characteristic pattern of lipid
abnormalities in patients with diabetes mellitus
consists of moderate elevation in triglycerides (TG),
low high-density lipoprotein cholesterol (HDL-C)
concentrations, and an increase in small dense low-
density lipoprotein cholesterol (LDL-C) particles [21].
To our knowledge, there has not been any study
that has examined lipid abnormalities of obese
patients with type 2 diabetes mellitus, and
hypertension in Jamaica. This study was designed
to investigate the pattern of lipid abnormalities in
obese and hypertensive type 2 diabetes mellitus
patients in the Jamaican adult population.
Material and methods
Sample design
We carried out a transverse study at the
University of the West Indies, with the purpose of
comparing the lipid profile of obese type 2 diabetic,
and hypertensive obese type 2 diabetic subjects
with their obese non-diabetic and hypertensive
obese non-diabetic counterparts respectively in the
Jamaican population. This design was adopted from
the Jamaican Labour Force Surveys (LFS) by the
Statistical Institute of Jamaica (STATIN) [22],
a statutory body in Jamaica with responsibility for
census and other official population studies. The
design adopted for the LFS was a two-stage
stratified sampling design, with the first stage being
a selection of areas, Enumeration Districts (ED) of
the Population Census, and the second stage being
a selection of dwellings. Each dwelling in the
sampling universe had an equal probability of being
selected for inclusion in the first stage. At the
homes visited, only individuals 15 years and over
were interviewed and included in the study.
A questionnaire was administered by members of
the health team to each participant; this included
personal, medical and family histories. Informed
consent was obtained after the nature of the
procedures had been fully explained to the
participants. Patients who did not complete the
investigations needed for this study, and those on
statins or fibrates, were excluded from the study.
In addition we excluded persons with disorders 
that predispose to hyperlipidaemia, such as
hypothyroidism and nephrotic syndrome.
At the homes of the participants a fasting blood
sample was taken. The fasting blood glucose
concentration for each group was determined by
using Reflolux S type 1 172 115 glucometers
(Boehringer Mannheim, Germany) [23]. All subjects
with a fasting blood glucose of 6.1 mmol/l or above
were asked to attend a nearby health facility, the
day after an overnight fast (12-14 hours), without
consuming anything that morning. At the health
facility, an abbreviated glucose tolerance test (GTT)
was conducted on each subject. Fasting blood
glucose (FBG) was measured on arrival at the clinic,
followed by a drink containing 75 g of glucose. Two
hours later a second blood glucose measurement
was taken. A fasting blood glucose of 6.7 mmol/lArch Med Sci 5, October / 2010 703
Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica
or above, or a two-hour postprandial blood glucose
of 11.1 mmol/l or above, was viewed as indicative
of diabetes mellitus [24]. The plasma glucose
concentration of the fasting and postprandial blood
samples were determined based on the glucose-
oxidase method using a multi-channel Abbott
Spectrum Autoanalyzer (Abbott Laboratories, Abbott
Park, USA). Glucose oxidase catalyses the oxidation
of glucose to gluconic acid. The generation of
hydrogen peroxide is indirectly measured by
oxidation of o-dianisidine in the presence of
peroxidase [25]. Obesity was defined as a body
mass index (BMI) of > 30 kg/m2, according to WHO
criteria [9]. Blood pressure (systolic and diastolic)
measurements were taken using a mercury
sphygmomanometer with standard technique by
a trained health professional [26]. Patients were
allowed to rest for 30 min. All measurements were
made in the morning between 9:00 and 10:00 a.m.
The mean of two blood pressures was recorded
while the patients were seated. Hypertension was
defined as a systolic blood pressure reading greater
than 140 mmHg and/or a diastolic reading greater
than 90 mmHg.
Biochemical analysis
Biochemical assays on the serum were
performed with a multi-channel Abbott Spectrum
Autoanalyzer (Abbott Laboratories, Abbott Park,
USA). Parameters that were determined include:
total cholesterol (TC), TG, HDL-C, LDL-C and 
very-low-density lipoprotein cholesterol (VLDL-C).
Total cholesterol was determined by an enzymatic
method. The cholesterol esters are hydrolyzed to
free cholesterol by cholesterol esterase. The free
cholesterol is then oxidized by cholesterol oxidase
to cholesten-3-one with the simultaneous
production of hydrogen peroxide. The hydrogen
peroxide produced couples with 4-aminoantipyrine
and phenol, in the presence of peroxidase, to yield
a chromogen with maximum absorbance at 505 nm
[27]. HDL-C was measured by an enzymatic method
on the supernatant obtained after selective
precipitation of apolipoprotein B-containing
lipoproteins with phosphotungstic acid in the
presence of magnesium ions and centrifugation
[28]. Triglyceride determination was carried out by
an analytical method based on the sequence of
reactions described by Fossati et al. [29]. In this
direct colorimetric procedure, serum triglycerides
are hydrolyzed by lipase, and the released glycerol
is assayed in a reaction catalyzed by glycerol 
kinase and L-alpha-glycerol-phosphate oxidase in
a system that generates hydrogen peroxide. 
The hydrogen peroxide is monitored in the presence
of horseradish peroxidase with 3,5-dichloro-2-
hydroxybenzenesulfonic acid/4-aminophenazone
as the chromogenic system. The absorbance of this
chromogen system is measured at 510 nm [29]. The
methods adopted by the automated instrument for
the determination of the above parameters are
according to the instructions of the manufacturer,
Abbott Laboratories (Abbott Diagnostics, Illinois,
USA). Serum LDL-C was calculated according to
computational procedures of Friedewald et al. [30]
(LDL = TC – HDL-C – TG/2.2 [mmol/l]). Calculation
of VLDL-C was 1/5 of TG concentration.
Statistical analysis
Values for the continuous variables are
expressed as mean ± SD. Comparisons of males and
females with obesity and type 2 diabetes mellitus,
and those with hypertension, obesity and type 2
diabetes mellitus, against their obese non-diabetic
and hypertensive obese non-diabetic counterparts,
respectively, were performed using unpaired
Student’s t test for independent samples; a level of
p < 0.05 was considered as statistically significant.
Independent observations were assumed using
Fisher’s exact test and 0.05 was taken to be the
cut-off for acceptability of significance levels. The
study parameters showed non-Gaussian distri  -
bution and statistical significance was assessed by
the Mann-Whitney U test [31]. Statistics were
computed using SPSS 11.5 (SPSS Inc., Chicago,
Illinois, United States).
Results
In the island-wide study, 2108 subjects were
studied, 402 type 2 diabetic (19.1%) and 1706 non-
diabetic subjects (80.9%). There were 117 obese
type 2 diabetics and 56 obese hypertensive type 2
diabetics. Of the non-diabetic subjects, 1179 were
non-diabetic without other diseases. There were
156 obese non-diabetics and 117 hypertensive obese
non-diabetics (Table I).
Obese type 2 diabetic males had significantly
higher serum concentrations of TG than their obese
non-diabetic counterparts (p = 0.039; Table II).
Characteristic Gender
Male Female Total
N (%) N (%) N
Obese type 2 diabetics 28 (24.0) 89 (76.0) 117 
Obese non-diabetics  59 (37.7) 97 (62.3) 156 
Hypertensive obese  22 (39.6) 34 (60.4) 56
type 2 diabetics 
Hypertensive obese  41 (35.2) 76 (64.8) 117
non-diabetics
Total 150 296 446
χ2 (df = 3) = 6.79, p = 0.005
Table I. Distribution of type 2 diabetes mellitus
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Similarly, obese type 2 diabetic females had
significantly higher serum concentrations of TG than
obese non-diabetic females (p = 0.019; Table III). 
Hypertensive obese type 2 diabetic males had
significantly higher mean serum concentrations of
TC (p = 0.031), TG (p = 0.007), LDL-C (p = 0.044) 
and TC/HDL-C ratio (p = 0.004) compared with
hypertensive obese non-diabetic males (Table IV).
Hypertensive obese type 2 diabetic females had
significantly higher mean serum concentrations of
TC (p = 0.043), TG (p = 0.046), LDL-C (p = 0.04),
TC/HDL-C ratio (p = 0.001) and LDL-C/HDL-C ratio
(p = 0.003) compared with hypertensive obese non-
diabetic females (Table V). 
Hypertensive obese type 2 diabetic females had
significantly higher serum concentrations of TC, TG
and TC/HDL-C (p < 0.05) than hypertensive obese
type 2 diabetic males. Hypertensive obese type 2
diabetic females had significantly higher mean
serum concentrations of TG (p = 0.03) and TC 
(p = 0.01) than obese type 2 diabetic females.
There was a significant association between
blood glucose and LDL-C concentrations in type 2
diabetic subjects (r = 0.36; 95% confidence limits
= 0.23 < r < 0.47; p < 0.05). In addition, there was
a significant correlation between blood glucose and
TC concentrations in type 2 diabetic subjects 
(r = 0.33; 95% confidence limits = 0.26 < r < 0.49;
p < 0.05).
Discussion
Diabetes mellitus is often associated with
cardiovascular morbidity and this may partly be
explained by the abnormal lipid profile which is
sometimes a feature of diabetes. We studied the
pattern of lipid abnormalities in a population of type
2 diabetic, obese and hypertensive subjects drawn
from the 14 parishes in Jamaica. The magnitude of
the detected abnormalities showed that TG was
the parameter that was most affected as it showed
the most significant mean difference between the
values of those patients in the obese type 2 diabetic
group, and their counterparts in the obese non-
diabetic group for both males and females, thus
implying a higher cardio-metabolic risk. The
hypertriglyceridaemia associated with obesity and
insulin resistance in type 2 diabetes was thought
to be secondary to the effects of elevated plasma
insulin levels causing increased hepatic fatty acid
Lipid profile Obese type 2  Obese p
[mmol/l] diabetic non-diabetic
Mean ± SD Mean ± SD
Triglyceride 1.65 ±0.61 1.45 ±0.79 0.039
LDL-C 3.23 ±0.96 2.78 ±1.00 0.161
VLDL-C 0.39 ±0.04 0.38 ±0.19 0.984
HDL-C 0.90 ±0.20 1.04 ±0.47 0.361
Total cholesterol 5.44 ±1.48 5.19 ±1.02 0.159
LDL/HDL ratio 3.84 ±0.98 3.03 ±0.67 0.100
TC/HDL ratio 6.83 ±1.73 5.63 ±0.60 0.089
Table II. Comparison of the lipid profile between
obese type 2 diabetic and obese non-diabetic males  
Lipid profile Obese type 2  Obese p
[mmol/l] diabetic non-diabetic
Mean ± SD Mean ± SD
Triglyceride 1.67 ±0.89 1.51 ±1.20 0.019
LDL-C 3.20 ±1.21 3.10 ±1.18 0.650
VLDL-C 0.43 ±0.30 0.39 ±0.09 0.699
HDL-C 1.07 ±0.65 1.29 ±0.36 0.216
Total cholesterol 5.80 ±1.54 5.68 ±1.68 0.721
LDL/HDL ratio 4.87 ±2.84 3.14 ±1.53 0.060
TC/HDL ratio 7.08 ±4.07 5.75 ±2.40 0.099
Table III. Comparison of the lipid profile between
obese type 2 diabetic and obese non-diabetic
females  
Lipid profile Hypertensive  Hypertensive  p
[mmol/l] obese obese 
type 2 diabetic non-diabetic
Mean ± SD Mean ± SD
Triglyceride 1.96 ±1.14 1.53 ±1.34 0.007
LDL-C 3.29 ±1.21 2.99 ±1.18 0.044
VLDL-C 0.43 ±0.90 0.35 ±0.07 0.538
HDL-C 1.07 ±0.43 1.08 ±0.43 0.835
Total cholesterol 5.37 ±1.61 4.67 ±1.38 0.031
LDL/HDL ratio 3.29 ±1.51 3.10 ±1.15 0.581
TC/HDL ratio 6.98 ±2.14 5.70 ±0.20 0.004
Table IV. Comparison of the lipid profile between
hypertensive obese type 2 diabetic and hypertensive
obese non-diabetic males  
Lipid profile Hypertensive  Hypertensive  p
[mmol/l] obese obese 
type 2 diabetic non-diabetic
Mean ± SD Mean ± SD
Triglyceride 2.00 ±0.34 1.76 ±0.43 0.046
LDL-C 3.42 ±1.18 2.87 ±0.92 0.041
VLDL-C 0.50 ±0.00 0.40 ±0.29 0.747
HDL-C 1.02 ±0.37 1.50 ±0.23 0.495
Total cholesterol 8.70 ±1.30 6.12 ±1.38 0.043
LDL/HDL ratio 4.01 ±1.68 3.56 ±1.25 0.003
TC/HDL ratio 8.16 ±2.50 5.90 ±1.62 0.001
Table V. Comparison of the lipid profile between
hypertensive obese type 2 diabetic and hypertensive
obese non-diabetic females  Arch Med Sci 5, October / 2010 705
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esterification, which forms triglyceride [32]. It has
been proposed that insulin resistance leads to
elevated TG levels in obesity through decreased
adipose tissue lipoprotein lipase activity [33].
The major risk factors in type 2 diabetes are
glycaemic status, dyslipidaemia and hypertension.
Type 2 diabetic patients have a high frequency of
atherogenic dyslipidaemia especially for TC and
LDL-C [34]. The parameters TC, TG, LDL-C and
TC/HDL-C ratio showed significant mean differences
between values in the hypertensive obese diabetic
subjects compared with the hypertensive obese
non-diabetics for both males and females. This
indicates that the presence of type 2 diabetes is
responsible for the more atherogenic pattern. The
finding of elevated LDL-C in hypertensive obese
type 2 diabetic subjects is of crucial importance as
it represents the first alarming risk for
cardiovascular diseases. According to the National
Cholesterol Education Program (NCEP) guidelines
LDL-C is the main target of cardiovascular disease
prevention [35]. Elevated cholesterol though not
usually regarded as highly predictive of
cardiovascular disease was noted in a significant
number of the participants in this study, particularly
females. The significance of screening for total
cholesterol in this study lies in the fact that it could
serve as a valuable screening measure for
dyslipidaemia. 
The significant elevation of TC/HDL-C ratio in
hypertensive obese diabetic males and females is
a key finding. A study by Kinosian et al. showed that
the TC/HDL-C ratio is a better predictor of
atherosclerosis and cardiovascular disease than any
other single lipid [36]. Individuals with increased
TC/HDL-C ratio were shown to exhibit resistance to
insulin-stimulated disposal and to have higher
blood pressure, increased TG concentration and
hyperinsulinaemia. Each of these factors being
a part of the metabolic syndrome is an independent
risk factor for cardiovascular disease [37]. The
hypertensive obese diabetic females in this study
had the highest TC/HDL-C ratio and mean TG
concentration, and are therefore at the greatest risk
for cardiovascular disease. 
Several large epidemiological and clinical studies
have found the LDL-C/HDL-C ratio to be an excellent
predictor of coronary heart disease risk and an
excellent monitor for the effectiveness of lipid-
lowering therapies [38-41]. Therefore it was important
to evaluate the LDL-C/HDL-C ratio of the participants
in this study. The increased LDL-C/HDL-C ratio
observed in the hypertensive obese type 2 diabetic
females and males in this study indicates an
increased risk of developing coronary heart disease
[42]. In the PROSPER trial, a retrospective analysis
of 6,000 patients, the ratio of LDL-C/HDL-C was the
most powerful measure of cardiovascular disease
risk in elderly people [43]. The researchers
concluded that changes in LDL-C/HDL-C ratio as
a result of statin treatment appeared to account for
the beneficial effects of therapy and suggested that
statin therapy could usefully be targeted to those
with an LDL-C/HDL-C ratio > 3.3 [43]. It is important
to note that while the mean LDL-C/HDL-C ratio of
the hypertensive obese type 2 diabetic males in this
study was 3.29, the value for the females was 4.01.
This indicates that the females are at greater risk
of developing cardiovascular disease and could
benefit more from statin therapy.
Hypertension is one of the most important
treatable causes of morbidity and mortality and
accounts for a large proportion of cardiovascular
diseases in the elderly in Jamaica [44]. The age-and
sex-adjusted prevalence in Jamaica is 24% [45], with
somewhat higher levels in women than in men. In
a paper published from the data in this study,
Ragoobirsingh et al. reported that Jamaica has
a point prevalence of hypertension of 30.8% in the
15-and-over age group. The main risk factors for
hypertension are being female, advancing age,
obesity, having diabetes and having a family history
of hypertension [46]. We report a higher significant
mean difference between TC and TG in
hypertensive obese type 2 diabetic females
compared with obese type 2 diabetic females. The
presence of hypertension may be contributory to
the greater prevalence of dyslipidaemia observed
in the former group. In explaining this scenario,
insulin resistance or compensatory hyper  -
insulinaemia has been associated with
hypertension and dyslipidaemia in cross-sectional
studies [47, 48]. Insulin resistance often leads to
increased intracellular hydrolysis of triglycerides
and release of fatty acids into the circulation. The
resultant inability of fat cells to store triglyceride is
the initial step in the development of dyslipidaemia.
Other plausible explanations for the contributory
effect of hypertension to abnormal lipid profiles in
diabetes mellitus include use of antihypertensive
agents [49]. Beta blockers and diuretics, especially
thiazide diuretics, have been found to negatively
affect the lipid profile and glucose tolerance.
Thiazides in high dosage and loop diuretics can
increase serum LDL-C, TG, TC/HDL-C ratio and often
TC [50]. These blood pressure lowering agents are
commonly used for the purpose of blood pressure
control in patients with diabetes and hypertension. 
Obesity, and especially intra-abdominal fat, is
strongly associated with insulin resistance, glucose
intolerance, and diabetes mellitus, and is a growing
problem in Jamaica [51]. Contributory to this is the
westernization of traditional Jamaican diets, with
fruits, vegetables, and whole grains being replaced
by readily-accessible fast foods, which are high in
saturated fat, sugars and refined carbohydrates. In706 Arch Med Sci 5, October / 2010
Lorenzo Gordon, Dalip Ragoobirsingh, Errol Morrison, Donovan McGrowder, Eric Choo-Kang, E. Martorell
another paper published from the data in this study,
Ragoobirsingh et al. reported that Jamaica has
a point prevalence of obesity, truncal 36.2% and
gynoid 34.1%, in the 15-and-over age group. Both
were affected by increasing age, being female, level
of education attained and smoking status [52].
Gender was found to be a possible determinant of
the pattern of lipid profile levels in participants in
the study. In particular, obesity was more prevalent
among females [52]. We report a higher significant
mean difference between TC, TG and TC/HDL-C
ratio in hypertensive obese type 2 diabetic females
compared with hypertensive obese type 2 diabetic
males, indicating a higher prevalence of lipid
abnormalities and greater atherogenic risk. King et
al. reported that the risk of coronary heart disease in
diabetic females is related to age, reproductive and
hormonal status as well as HDL-C, TC and TG [53].
A high dietary energy and fat intake is likely to
be a major contributing factor to the high
prevalence of obesity and evidence of dyslipidaemia
in the Jamaican population, particularly those living
in urban areas. There is the westernization of
traditional Jamaican diets, with fruits, vegetables,
and whole grains being replaced by readily-accessible
fast foods, which are high in saturated fat, sugars
and refined carbohydrates. However, a high dietary
fat intake alone cannot account for the extent of
the problem. In Jamaica, there is a cultural
acceptance of obesity, especially in women [54].
Fewer than half of the subjects recognized poor diet
and/or overweight as contributing to their diabetes.
Firmly rooted social and economic factors actively
encourage over-eating and sedentary behaviour and
discourage alterations in these patterns [55]. Physical
inactivity among the participants may be
a significant contributory factor of their obesity, as
a national study recently conducted in Jamaica
revealed that only 21.6% of the sample participated
in planned exercise [56]. Furthermore, indiscriminate
eating patterns could have a direct and unfavourable
influence on weight management and glycaemic
control. 
Despite the importance of these findings of
dyslipidaemia and increased atherogenic risk in
hypertensive obese type 2 diabetics, and obese type
2 diabetics in a representative sample of the Jamaican
population, there are some limitations in the study.
We did not acquire any information about the
hormonal status of our women subjects. Thus, we do
not know whether these women went through earlier
menopause and whether this was related to
redistribution of fat. Physical activity was not
considered and the amount of alcohol and tobacco
use was not quantified in our study. These 3 lifestyle
factors have been reported to be quantitatively
correlated with plasma lipid levels [57, 58]. Also, data
on the socioeconomic status of the patients were not
available, to check for its influence on the
dyslipidaemic state of the participants. The study
could have been strengthened by the measurement
of anthropometric variables such as higher waist
circumference, BMI and waist-to-hip ratio, as these
have been found to be significantly associated with
dyslipidaemia in males and females. 
In conclusions, obesity is a significant problem
in the Caribbean countries, including Jamaica, and
it is associated with a high prevalence of
hypertension, particularly in women. Our study
provided evidence for the presence of significant
dyslipidaemia in obese type 2 diabetes mellitus and
hypertensive obese type 2 diabetes mellitus
patients. Future research should focus on
intervention strategies aimed at reducing obesity
and its morbid sequelae. These strategies should
be culturally specific, with a particular focus on
children and women, and should include dietary
and behavioural aspects, weight reduction,
increased physical activity, improved glycaemic
control, and increased HDL cholesterol levels, along
with reduced LDL cholesterol.
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